Literature DB >> 23756399

The role of oxidative stress in acetylcholine-induced relaxation of endothelium-denuded arteries.

S Cacanyiova1, I Dovinova, F Kristek.   

Abstract

Nitric oxide (NO) is produced in the endothelium in response to vasorelaxants, such as acetylcholine, and acts on vascular smooth muscle cells to induce vasorelaxation. Previously, we found that the smooth muscle of endothelium-denuded arteries expresses functional NO synthase. We hypothesized that the destruction of arterial anatomical integrity induced by denuding arteries of their endothelial layers causes the vessels to become insensitive to vasodilators as a consequence of oxidative stress. In this study, we examined whether the acetylcholine-induced vasorelaxation observed in deendothelialized arteries is mediated by NO and/or affected by oxidative stress. For functional relaxation studies, the isolated thoracic aorta and pulmonary artery of male Wistar rats were used. Vessel superoxide production was assessed in preserved and endothelium-denuded arteries by the lucigenin chemiluminescence method. In all arteries with intact endothelia, acetylcholine evoked vasorelaxation; this effect was inhibited in endothelium-denuded rings. Pretreatment of denuded rings with the free-radical scavenger tempol improved acetylcholine-induced relaxation. This effect was inhibited by the coadministration of 1H-[1,2,4]oxadiazolo[4,3-α]quinoxalin-1-one (ODQ), an inhibitor of guanylate cyclase, or N(G)-nitro-L-arginine methylester (L-NAME), an inhibitor of NO synthase. The chemiluminescent assay revealed that endothelial denudation of both vessel types increased the production of superoxide radicals which has been decreased after tempol administration. Our results show that non-endothelial NO could represent an additional source of physiologically active NO and that the insensitivity of endothelium-denuded vessels to vasodilators could be a consequence of oxidative stress. These findings question the concept that endothelial cells play an obligatory role in vasorelaxation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23756399

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  5 in total

Review 1.  New insights into the role of soluble guanylate cyclase in blood pressure regulation.

Authors:  Emmanuel Buys; Patrick Sips
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-03       Impact factor: 2.894

2.  Wall stretch and thromboxane A₂ activate NO synthase (eNOS) in pulmonary arterial smooth muscle cells via H₂O₂ and Akt-dependent phosphorylation.

Authors:  Hae Jin Kim; Hae Young Yoo; Ji Hyun Jang; Hai Yue Lin; Eun Yeong Seo; Yin Hua Zhang; Sung Joon Kim
Journal:  Pflugers Arch       Date:  2016-01-04       Impact factor: 3.657

Review 3.  The role of nitric oxide in peptic ulcer: a narrative review.

Authors:  Tian-Yu Liang; Ru-Ming Deng; Xiang Li; Xiang Xu; Gang Chen
Journal:  Med Gas Res       Date:  2021 Jan-Mar

4.  Fast relaxation and desensitization of angiotensin II contraction in the pulmonary artery via AT1R and Akt-mediated phosphorylation of muscular eNOS.

Authors:  Hae Jin Kim; Ji Hyun Jang; Yin Hua Zhang; Hae Young Yoo; Sung Joon Kim
Journal:  Pflugers Arch       Date:  2019-08-30       Impact factor: 4.458

5.  The novel analogue of hirsutine as an anti-hypertension and vasodilatary agent both in vitro and in vivo.

Authors:  Kai Zhu; Su-Na Yang; Fen-Fen Ma; Xian-Feng Gu; Yi-Chun Zhu; Yi-Zhun Zhu
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.